Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05217_nanopub.RA5uQXRJTpN6E1or7gdG5GUVA_itIcpwuwthcCNv12O2o#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05217 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05217 label "GMX1777 [drugbank:DB05217]" assertion.
- drugbank:DB05217 seeAlso DB05217 assertion.
- drugbank:DB05217 description "GMX1777 is a water-soluble prodrug of the cyanoguanidine compound GMX1778 with potential antineoplastic activity. In vivo, apoptosis inducer GMX1777 is rapidly converted into GMX1778 through hydrolytic cleavage of a carbonate ester bond. Although the exact mechanism of action has yet to be fully elucidated, GMX1778 appears to antagonize nuclear factor-kappa B (NF-kB) transcription, resulting in the induction of tumor cell apoptosis." assertion.
- drugbank:DB05217 identifier "drugbank:DB05217" assertion.
- drugbank:DB05217 title "GMX1777" assertion.
- drugbank:DB05217 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05217 drugbank_vocabulary:drugbank-id "DB05217" assertion.
- drugbank:DB05217 bio2rdf_vocabulary:x-identifiers.org DB05217 assertion.
- drugbank:DB05217 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05217" assertion.
- drugbank:DB05217 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05217 bio2rdf_vocabulary:identifier "DB05217" assertion.